Cargando…

Real-world data of six patients with atypical hemolytic uremic syndrome switched to ravulizumab

Detalles Bibliográficos
Autores principales:	Ehren, Rasmus, Habbig, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445866/ https://www.ncbi.nlm.nih.gov/pubmed/34274988 http://dx.doi.org/10.1007/s00467-021-05203-8

Ejemplares similares

Ravulizumab in Preemptive Living Donor Kidney Transplantation in Hereditary Atypical Hemolytic Uremic Syndrome
por: Schmidt, Tilman, et al.
Publicado: (2022)

Eculizumab Versus Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome: A Systematic Review
por: Shahid, Kamran, et al.
Publicado: (2023)

Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome
por: Mauch, Teri J, et al.
Publicado: (2023)

An Unusual cause of Atypical Hemolytic Uremic Syndrome Relapse
por: Mert, Mehmet, et al.
Publicado: (2022)

Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: An indirect comparison using clinical trial data
por: Tomazos, Ioannis, et al.
Publicado: (2022)

Hepatitis B Vaccine-Associated Atypical Hemolytic Uremic Syndrome
por: Avcı, Zekai, et al.
Publicado: (2013)

Long-term renal function under plasma exchange in atypical hemolytic uremic syndrome
por: Davin, Jean-Claude, et al.
Publicado: (2011)

Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulation
por: Davin, Jean-Claude, et al.
Publicado: (2010)

Drug-induced hemolytic uremic syndrome
por: Cavoli, G. Li, et al.
Publicado: (2011)

The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab
por: Tanaka, Kazuki, et al.
Publicado: (2020)

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults
por: Barbour, Thomas, et al.
Publicado: (2021)

Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011)

Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013)

Thrombotic Microangiopathy with Complement Factor H Gene Mutations Unassociated with Atypical Hemolytic Uremic Syndrome
por: Oymak, Yeşim, et al.
Publicado: (2015)

Thrombotic Microangiopathic Hemolytic Anemia without Evidence of Hemolytic Uremic Syndrome
por: Özsoylu, Şinasi
Publicado: (2016)

Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis
por: Gäckler, Anja, et al.
Publicado: (2021)

First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
por: Jehn, Ulrich, et al.
Publicado: (2022)

CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency
por: Bouts, Antonia H., et al.
Publicado: (2010)

Digital gangrene in a child with atypical hemolytic uremic syndrome associated with anti-factor H antibodies
por: Sathe, K. P., et al.
Publicado: (2016)

Pathogenesis of Atypical Hemolytic Uremic Syndrome
por: Yoshida, Yoko, et al.
Publicado: (2019)

The genetics of atypical hemolytic uremic syndrome
por: Feitz, Wouter J. C., et al.
Publicado: (2018)

Correction to: Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis
por: Gäckler, Anja, et al.
Publicado: (2021)

Atypical Hemolytic Uremic Syndrome Treated With Ravulizumab or Eculizumab: A Claims-Based Evaluation of Health Care Resource Utilization and Clinical Outcomes in the United States
por: Wang, Yan, et al.
Publicado: (2023)

Plasmodium vivax malaria presenting as hemolytic uremic syndrome
por: Patel, M. P., et al.
Publicado: (2013)

Complement activation in children with Streptococcus pneumoniae associated hemolytic uremic syndrome
por: Holle, Johannes, et al.
Publicado: (2021)

How atypical can Atypical Hemolytic Uremic Syndrome be?
por: Sajan, Thomas, et al.
Publicado: (2014)

A case of atypical hemolytic uremic syndrome associated with the c.1273C>T mutation in the complement C3 gene
por: Cho, Hye Jeong, et al.
Publicado: (2016)

Home-prepared Hamburger and Sporadic Hemolytic Uremic Syndrome, Argentina
por: Rivas, Marta, et al.
Publicado: (2003)

Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome
por: Saad, Antonio F., et al.
Publicado: (2016)

Complement and the atypical hemolytic uremic syndrome in children
por: Loirat, Chantal, et al.
Publicado: (2008)

Pediatric Atypical Hemolytic Uremic Syndrome Advances
por: Raina, Rupesh, et al.
Publicado: (2021)

Pregnancy-related atypical hemolytic uremic syndrome with renal, cardiac and obstetric complications and a satisfactory recovery: a case report
por: Gunay, Emrah, et al.
Publicado: (2021)

Factor B Mutation in Monozygotic Twins Discordant for Atypical Hemolytic Uremic Syndrome
por: Aradottir, Sigridur Sunna, et al.
Publicado: (2023)

Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic
por: Tatar, Erhan, et al.
Publicado: (2021)

Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
por: Cammett, Tobin J., et al.
Publicado: (2022)

Assesment, Treatment and Prevention of Atypical Hemolytic Uremic Syndrome
por: Nickavar, Azar, et al.
Publicado: (2013)

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
por: Palma, Lilian M Pereira, et al.
Publicado: (2016)

Atypical hemolytic uremic syndrome and eculizumab therapy in children
por: Kim, Seong Heon, et al.
Publicado: (2018)

Atypical Hemolytic Uremic Syndrome: A Case Report
por: Mohammed, Sohaib K, et al.
Publicado: (2019)

Atypical hemolytic uremic syndrome triggered by varicella infection
por: Condom, Pauline, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ma4ms8bnkno2g5huhieo6l7vg4